BackCocrystal Pharma Overview

Cocrystal Pharma EBIT

EBIT (Earnings Before Interest and Taxes) analysis for COCP.

Quarterly EBIT

-$2.36M
0.64% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$9.09M
43.42% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)